Evidence map›Paper›PMID 25486360›Full record

ArticleCell cycle (Georgetown, Tex.)2014

Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase.

Erik Müllers, Helena Silva Cascales, Himjyot Jaiswal, Adrian T Saurin, Arne Lindqvist

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Surviving the Storm: The Role of Poly- and Depolyploidization in Tissues and Tumors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. The molecular architecture of cell cycle arrest.Molecular systems biology · 2022
    Article
  19. Article
  20. MDC1 is essential for G2/M transition and spindle assembly in mouse oocytes.Cellular and molecular life sciences : CMLS · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 5 countries.

Erik Müllersa Department of Cell and Molecular Biology; Karolinska Institutet ; Stockholm , Sweden.
Helena Silva Cascales
Himjyot Jaiswal
Adrian T Saurin
Arne Lindqvist
Karolinska Institutet · SEUniversity of Dundee · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Upon DNA damage, cell cycle progression is temporally blocked to avoid propagation of mutations. While transformed cells largely maintain the competence to recover from a cell cycle arrest, untransformed cells past the G1/S transition lose mitotic inducers, and thus the ability to resume cell division. This permanent cell cycle exit depends on p21, p53, and APC/C(Cdh1). However, when and how permanent cell cycle exit occurs remains unclear. Here, we have investigated the cell cycle response to DNA damage in single cells that express Cyclin B1 fused to eYFP at the endogenous locus. We find that upon DNA damage Cyclin B1-eYFP continues to accumulate up to a threshold level, which is reached only in G2 phase. Above this threshold, a p21 and p53-dependent nuclear translocation required for APC/C(Cdh1)-mediated Cyclin B1-eYFP degradation is initiated. Thus, cell cycle exit is decoupled from activation of the DNA damage response in a manner that correlates to Cyclin B1 levels, suggesting that G2 activities directly feed into the decision for cell cycle exit. Once Cyclin B1-eYFP nuclear translocation occurs, checkpoint inhibition can no longer promote mitotic entry or re-expression of mitotic inducers, suggesting that nuclear translocation of Cyclin B1 marks the restriction point for permanent cell cycle exit in G2 phase.

Indexed as

Cell Cycle CheckpointsG2 PhaseAnaphase-Promoting Complex-CyclosomeCell Line, TumorCell NucleusCyclin B1Cyclin-Dependent Kinase Inhibitor p21DNA DamageGene TargetingHumansProtein TransportProteolysisTumor Suppressor Protein p53Anaphase-Promoting Complex-CyclosomeCyclin B1Cyclin-Dependent Kinase Inhibitor p21Tumor Suppressor Protein p53APC/C, anaphase-promoting complex/cyclosomeATM, Ataxia telangiectasia mutated kinaseATR, Ataxia telangiectasia and Rad3 related kinaseAU, arbitrary unitsCdk, cyclin-dependent kinasecell cyclecheckpoint recoveryChk1/2, checkpoint kinase 1/2Cyclin B1DDR, DNA damage responseDNA damage responseDNA-PK, DNA-dependent protein kinaseG2 phaseH2AX, phosphorylated on serine 139LMB, Leptomycin BMdm2, mouse double minute 2 homologMK2, MAPKAP kinase 2NCS, Neocarzinostatinnuclear translocation recovery competencePlk1, polo-like kinase 1senescenceγH2AX, histone variant

Identifiers

PMID25486360
PMCPMC4615111
OpenAlexW2026111663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.